Header Logo

Connection

Ekihiro Seki to Disease Models, Animal

This is a "connection" page, showing publications Ekihiro Seki has written about Disease Models, Animal.
Connection Strength

1.869
  1. Repurposing of the analgesic Neurotropin for MASLD/MASH treatment. Hepatol Commun. 2024 08 01; 8(8).
    View in: PubMed
    Score: 0.805
  2. Loss of fungal sensing exacerbates liver injury in a murine model of MASLD. JCI Insight. 2026 Apr 22; 11(8).
    View in: PubMed
    Score: 0.225
  3. Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models. Elife. 2022 10 04; 11.
    View in: PubMed
    Score: 0.178
  4. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. Proc Natl Acad Sci U S A. 2021 01 05; 118(1).
    View in: PubMed
    Score: 0.157
  5. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol. 2015 Jul 01; 309(1):G30-41.
    View in: PubMed
    Score: 0.106
  6. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology. 2014 Feb; 59(2):483-95.
    View in: PubMed
    Score: 0.097
  7. Selective inhibition of long isoforms of phosphodiesterase 4D mitigates liver fibrosis in mouse models. J Clin Invest. 2026 01 02; 136(1).
    View in: PubMed
    Score: 0.055
  8. Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5/Smad signalling. Gut. 2019 12; 68(12):2214-2227.
    View in: PubMed
    Score: 0.035
  9. Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2018 10 16; 115(42):E9879-E9888.
    View in: PubMed
    Score: 0.034
  10. Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells. PLoS One. 2016; 11(3):e0150893.
    View in: PubMed
    Score: 0.028
  11. Nrf2 activation protects the liver from ischemia/reperfusion injury in mice. Ann Surg. 2014 Jul; 260(1):118-27.
    View in: PubMed
    Score: 0.025
  12. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. Hepatology. 2014 Jul; 60(1):237-49.
    View in: PubMed
    Score: 0.025
  13. A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J Hepatol. 2014 Apr; 60(4):782-91.
    View in: PubMed
    Score: 0.024
  14. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology. 2008 Dec; 48(6):2016-26.
    View in: PubMed
    Score: 0.017
  15. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology. 2008 Nov; 135(5):1729-38.
    View in: PubMed
    Score: 0.017
  16. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol. 2007 Sep; 293(3):G631-9.
    View in: PubMed
    Score: 0.015
  17. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology. 2006 Aug; 44(2):420-9.
    View in: PubMed
    Score: 0.014
  18. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology. 2003 Aug; 38(2):335-44.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.